Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Rheumatology and Therapy|June 9, 2023
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO RegistryEmine Duran, Zeynep Ozge Ozturk, Emre Bilgin, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective dataGezmiş Kimyon, Umut Kalyoncu, Sedat Kiraz, et al.
Clinical and Experimental Rheumatology|October 1, 2025
Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort studyHasan Satiş, Ahmet Gül, Gizem Ayan, et al.
Turkish Journal of Medical Sciences|February 21, 2021
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemicUmut Kalyoncu, Yavuz Pehlivan, Servet Akar, et al.
Archives of Rheumatology|December 4, 2023
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure databaseEmine Duygu Ersözlü, Mustafa Ekici, Belkis Nihan Coşkun, et al.
International Journal of Rheumatic Diseases|December 6, 2023
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality ratesGüllü Sandal Uzun, Arzu Taghiyeva, İbrahim Y Çakır, et al.
Rheumatology (Oxford, England)|June 24, 2023
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up studyBurcu Yagiz, Nihal Lermi, Belkis N Coskun, et al.
Rheumatology International|July 6, 2021
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?Burcu Yagiz, Belkis Nihan Coskun, Yavuz Pehlivan, et al.
Clinical and Experimental Rheumatology|April 3, 2026
Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritisFatma Alibaz-Oner, Mete Kara, Sinem Nihal Esatoglu, et al.
Medicine|February 13, 2015
Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapsesFatma Alibaz-Oner, Asl Karadeniz, Sema Ylmaz, et al.
Pageof 10